Difference in response of D2 receptor binding between11C-N-methylspiperone and11C-raclopride against anesthetics in rhesus monkey brain

This publication has 8 references indexed in Scilit:

• Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey
  Brain Research, 1994
• A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphme ([11C]diprenorphine) in baboon using PET
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
• Effects of endogenous dopamine on kinetics of [³H]N‐methylspiperone and [³H]raclopride binding in the rat brain
  Synapse, 1991
• Nomifensine‐induced increased in extracellular striatal dopamine is enhanced by isoflurane anaesthesia
  Synapse, 1991
• Difference in in vivo receptor binding between [3 H]N-methylspiperone and [3 H]raclopride in reserpine-treated mouse brain
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
• Mapping muscarinic receptors in human and baboon brain using [N‐¹¹C‐methyl]‐benztropine
  Synapse, 1990
• Endogenous dopamine lowers the dopamine D₂ receptor density as measured by [³H]raclopride: Implications for positron emission tomography of the human brain
  Synapse, 1989
• PET measurement of D2 and S2 receptor binding of 3-N-([2?-18F]fluoroethyl)spiperone in baboon brain
  European Journal of Nuclear Medicine and Molecular Imaging, 1988